Exhibit 2
Joint Filing Statement Statement
Pursuant to Rule13d-1(k)(1)
The undersigned hereby consent and agree to file a joint statement on Schedule 13D under the Securities Exchange Act of 1934, as amended, with respect to the common stock, $0.01 par value, of Rocket Pharmaceuticals, Inc. beneficially owned by them, together with any or all amendments thereto, when and if appropriate. The parties hereto further consent and agree to file this Joint Filing Statement pursuant toRule13d-1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into such Schedule 13D.
This Joint Filing Statement may be terminated by any of the undersigned upon written notice or such lesser period of notice as the undersigned may mutually agree.
Dated: January 16, 2018
| RTW Investments, LP | ||
| By: | /s/ Roderick Wong | |
| Roderick Wong, Managing Partner | ||
| Roderick Wong | ||
| By: | /s/ Roderick Wong | |
| Roderick Wong, Individually | ||
